CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
Open Access
- 6 August 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (16) , 5656
Abstract
Starting from the recent identification of CD36 and CD97 as a novel marker combination of fibroblast quiescence in lung during fibrosis, we aimed to survey the literature in search for facts about the separate (or concomitant) expression of clusters of differentiation CD36 and CD97 in either tumor- or pancreatic-cancer-associated cells. Here, we provide an account of the current knowledge on the diversity of the cellular functions of CD36 and CD97 and explore their potential (common) contributions to key cellular events in oncogenesis or metastasis development. Emphasis is placed on quiescence as an underexplored mechanism and/or potential target in therapy. Furthermore, we discuss intricate signaling mechanisms and networks involving CD36 and CD97 that may regulate different subpopulations of tumor-associated cells, such as cancer-associated fibroblasts, adipocyte-associated fibroblasts, tumor-associated macrophages, or neutrophils, during aggressive pancreatic cancer. The coexistence of quiescence and activated states in cancer-associated cell subtypes during pancreatic cancer should be better documented, in different histological forms. Remodeling of the local microenvironment may also change the balance between growth and dormant state. Taking advantage of the reported data in different other tissue types, we explore the possibility to induce quiescence (similar to that observed in normal cells), as a therapeutic option to delay the currently observed clinical outcome.Keywords
Funding Information
- Romanian Ministry of Education and Research, UEFISCDI (7PFE/16.10.2018; PN 19.29.01.04; POC-A.1.1.4-E, P_37_794)
This publication has 233 references indexed in Scilit:
- CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancerProceedings of the National Academy of Sciences, 2013
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- VEGF-A and Tenascin-C produced by S100A4 + stromal cells are important for metastatic colonizationProceedings of the National Academy of Sciences, 2011
- Analysis of the Human Pancreatic Stellate Cell Secreted ProteomePancreas, 2011
- Hepatic stellate cell lipid droplets: A specialized lipid droplet for retinoid storageBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesisProceedings of the National Academy of Sciences, 2009
- GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformationGenes & Development, 2009
- Oncogenes and CancerNew England Journal of Medicine, 2008
- Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerGenes & Development, 2006
- Myofibroblasts and mechano-regulation of connective tissue remodellingNature Reviews Molecular Cell Biology, 2002